Adenovir Pharma AB
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- Holding
- Established
- 2008-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.adenovir.com
Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC)
Phase 2
Completed
- Conditions
- Viral Conjunctivitis
- Interventions
- Drug: APD-209 Eye dropsDrug: APD-209 Placebo Eye drops
- First Posted Date
- 2013-11-06
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Adenovir Pharma AB
- Target Recruit Count
- 47
- Registration Number
- NCT01977443
- Locations
- 🇵🇱
Katowice University Hospital, Katowice, Poland
🇸🇪St Eriks Eye Hospital, Stockholm, Sweden
🇵🇱P. Oleksy Centrum Medyczne Uno-Med, Tarnow, Poland
© Copyright 2025. All Rights Reserved by MedPath